| II-025 Nadja Haas Pharmacometric analysis of symptom burden during anti-cancer drug therapy by a Markov modelling approach Wednesday 15:20-16:50 |
| II-027 Nina Hanke Population pharmacokinetic-pharmacodynamic modeling of the iclepertin drug effect on hemoglobin levels Wednesday 15:20-16:50 |
| III-030 Marcel Mohr Integrated In Vitro/In Silico Systems Immunology Model to Quantify Drug-Induced Changes in the Immune Response after Influenza A Virus Infection – A Blueprint for the Preclinical Assessment and Clinical Translation of Infection Risks for Biologics Thursday 09:50-11:20 |
| III-056 Joanna Parkinson A streamlined, semi-automated workflow allows quick and efficient QTc and other ECG intervals modeling assessment, saving time and cost. Thursday 09:50-11:20 |
| IV-024 Bae Sungyeun Population pharmacokinetics of intravenous MIT-001 in healthy subjects and patients Thursday 15:00-16:30 |
